258 related articles for article (PubMed ID: 19304275)
21. Oxidized phospholipids protect against lung injury and endothelial barrier dysfunction caused by heat-inactivated Staphylococcus aureus.
Meliton AY; Meng F; Tian Y; Sarich N; Mutlu GM; Birukova AA; Birukov KG
Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(6):L550-62. PubMed ID: 25575515
[TBL] [Abstract][Full Text] [Related]
22. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
[TBL] [Abstract][Full Text] [Related]
23. Accumulating evidence for a role of oxidized phospholipids in infectious diseases.
Matt U; Sharif O; Martins R; Knapp S
Cell Mol Life Sci; 2015 Mar; 72(6):1059-71. PubMed ID: 25410378
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E receptor-4 receptor mediates endothelial barrier-enhancing and anti-inflammatory effects of oxidized phospholipids.
Oskolkova O; Gawlak G; Tian Y; Ke Y; Sarich N; Son S; Andreasson K; Bochkov VN; Birukova AA; Birukov KG
FASEB J; 2017 Sep; 31(9):4187-4202. PubMed ID: 28572443
[TBL] [Abstract][Full Text] [Related]
25. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.
Gao D; Podrez EA
Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052
[TBL] [Abstract][Full Text] [Related]
26. Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids.
Bochkov V; Schoenenberger AW; Oskolkova O; Toth U; Stöckl J; Majdic O; Daci A; Resink TJ; Erne P; Philippova M
Biomark Med; 2016 Aug; 10(8):797-810. PubMed ID: 27416002
[TBL] [Abstract][Full Text] [Related]
27. ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response.
Oskolkova OV; Afonyushkin T; Leitner A; von Schlieffen E; Gargalovic PS; Lusis AJ; Binder BR; Bochkov VN
Blood; 2008 Jul; 112(2):330-9. PubMed ID: 18451308
[TBL] [Abstract][Full Text] [Related]
28. Oxidized phospholipids on alkyl-amide scaffold demonstrate anti-endotoxin and endothelial barrier-protective properties.
Oskolkova OV; Hodzic A; Karki P; Gesslbauer B; Ke Y; Hofer DC; Bogner-Strauss JG; Galano JM; Oger C; Birukova A; Durand T; Birukov K; Bochkov V
Free Radic Biol Med; 2021 Oct; 174():264-271. PubMed ID: 34371153
[TBL] [Abstract][Full Text] [Related]
29. Hormetic and anti-inflammatory properties of oxidized phospholipids.
Mauerhofer C; Philippova M; Oskolkova OV; Bochkov VN
Mol Aspects Med; 2016 Jun; 49():78-90. PubMed ID: 26948981
[TBL] [Abstract][Full Text] [Related]
30. Structural identification and cardiovascular activities of oxidized phospholipids.
Salomon RG
Circ Res; 2012 Sep; 111(7):930-46. PubMed ID: 22982874
[TBL] [Abstract][Full Text] [Related]
31. Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction.
DeFilippis AP; Chernyavskiy I; Amraotkar AR; Trainor PJ; Kothari S; Ismail I; Hargis CW; Korley FK; Leibundgut G; Tsimikas S; Rai SN; Bhatnagar A
J Thromb Thrombolysis; 2016 Jul; 42(1):61-76. PubMed ID: 26510751
[TBL] [Abstract][Full Text] [Related]
32. Oxidized PLs and vascular inflammation.
Aldrovandi M; O'Donnell VB
Curr Atheroscler Rep; 2013 May; 15(5):323. PubMed ID: 23512607
[TBL] [Abstract][Full Text] [Related]
33. Oxidized phospholipids as modulators of inflammation in atherosclerosis.
Leitinger N
Curr Opin Lipidol; 2003 Oct; 14(5):421-30. PubMed ID: 14501580
[TBL] [Abstract][Full Text] [Related]
34. Oxidized phospholipids: emerging lipid mediators in pathophysiology.
Deigner HP; Hermetter A
Curr Opin Lipidol; 2008 Jun; 19(3):289-94. PubMed ID: 18460921
[TBL] [Abstract][Full Text] [Related]
35. Generation and biological activities of oxidized phospholipids.
Bochkov VN; Oskolkova OV; Birukov KG; Levonen AL; Binder CJ; Stöckl J
Antioxid Redox Signal; 2010 Apr; 12(8):1009-59. PubMed ID: 19686040
[TBL] [Abstract][Full Text] [Related]
36. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
Tsimikas S; Aikawa M; Miller FJ; Miller ER; Torzewski M; Lentz SR; Bergmark C; Heistad DD; Libby P; Witztum JL
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):175-81. PubMed ID: 17082490
[TBL] [Abstract][Full Text] [Related]
37. CHARMM GUI Membrane Builder for oxidized phospholipid membrane modeling and simulation.
Brown TP; Santa DE; Berger BA; Kong L; Wittenberg NJ; Im W
Curr Opin Struct Biol; 2024 Jun; 86():102813. PubMed ID: 38598982
[TBL] [Abstract][Full Text] [Related]
38. Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction.
Meng F; Meliton A; Moldobaeva N; Mutlu G; Kawasaki Y; Akiyama T; Birukova AA
Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(5):L452-63. PubMed ID: 25539852
[TBL] [Abstract][Full Text] [Related]
39. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids.
Singleton PA; Chatchavalvanich S; Fu P; Xing J; Birukova AA; Fortune JA; Klibanov AM; Garcia JG; Birukov KG
Circ Res; 2009 Apr; 104(8):978-86. PubMed ID: 19286607
[TBL] [Abstract][Full Text] [Related]
40. Oxidized lipids: the two faces of vascular inflammation.
Birukov KG
Curr Atheroscler Rep; 2006 May; 8(3):223-31. PubMed ID: 16640959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
